Literature DB >> 2919182

Sulfation of tyrosine residues increases activity of the fourth component of complement.

G L Hortin1, T C Farries, J P Graham, J P Atkinson.   

Abstract

Sulfation of tyrosine residues recently has been recognized as a biosynthetic modification of many plasma proteins and other secretory proteins. Effects of this site-specific modification on protein function are not known, but the activity of several peptides such as cholecystokinin is greatly augmented by sulfation. Here, we examine the role of sulfation in the processing and activity of C4 (the fourth component of complement), one of the few proteins in which sites and stoichiometry of tyrosine sulfation have been characterized. Our results, with C4 as a paradigm, suggest that sulfation of tyrosine residues can have major effects on the activity of proteins participating in protein-protein interactions. Sulfation of C4 synthesized by Hep G2 cells was blocked by incubating the cells with NaClO3 and guaiacol. These sulfation inhibitors did not alter secretion or other steps in the processing of C4. However, hemolytic activity of C4 was decreased more than 50%. The inhibitors' effect on C4 activity was prevented by adding Na2SO4 to restore sulfation of C4. Activity of C3, a complement component homologous to C4 but lacking tyrosine sulfate residues, was minimally reduced (19%) by the inhibitors. Decreased hemolytic activity of nonsulfated C4 apparently resulted from impaired interaction with complement subcomponent C1s (EC 3.4.21.42), the protease that physiologically activates C4. Purified C1s was able to cleave nonsulfated C4, but approximately 10-fold higher concentrations of C1s were required for that cleavage than to yield equivalent cleavage of sulfated C4. Our results suggest that activation of C4, a central component in the classical pathway of complement activation, is influenced by the level of sulfation of the protein. Thus, sulfation of C4 provides a potential locus for physiological or pharmacological modulation of complement-mediated opsonization and inflammation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2919182      PMCID: PMC286685          DOI: 10.1073/pnas.86.4.1338

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  57 in total

1.  THE ANTRAL HORMONE GASTRIN. STRUCTURE OF GASTRIN.

Authors:  H GREGORY; P M HARDY; D S JONES; G W KENNER; R C SHEPPARD
Journal:  Nature       Date:  1964-12-05       Impact factor: 49.962

Review 2.  A structural model for the location of the Rodgers and the Chido antigenic determinants and their correlation with the human complement component C4A/C4B isotypes.

Authors:  C Y Yu; R D Campbell; R R Porter
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

3.  Inhibitors of the sulfation of proteins, glycoproteins, and proteoglycans.

Authors:  G L Hortin; M Schilling; J P Graham
Journal:  Biochem Biophys Res Commun       Date:  1988-01-15       Impact factor: 3.575

4.  Complement polymorphism, the major histocompatibility complex and associated diseases: a speculation.

Authors:  R R Porter
Journal:  Mol Biol Med       Date:  1983-07

Review 5.  Tyrosine sulfation and the secretory pathway.

Authors:  W B Huttner
Journal:  Annu Rev Physiol       Date:  1988       Impact factor: 19.318

6.  Relationship between C4 null genes, HLA-D region antigens, and genetic susceptibility to systemic lupus erythematosus in Caucasian and black Americans.

Authors:  P F Howard; M C Hochberg; W B Bias; F C Arnett; R H McLean
Journal:  Am J Med       Date:  1986-08       Impact factor: 4.965

7.  Deficiency of C4A is a genetic determinant of systemic lupus erythematosus in three ethnic groups.

Authors:  H Dunckley; P A Gatenby; B Hawkins; S Naito; S W Serjeantson
Journal:  J Immunogenet       Date:  1987 Aug-Oct

8.  Protein stabilization via hydrophilization. Covalent modification of trypsin and alpha-chymotrypsin.

Authors:  V V Mozhaev; V A Siksnis; N S Melik-Nubarov; N Z Galkantaite; G J Denis; E P Butkus; N M Mestechkina; K Martinek
Journal:  Eur J Biochem       Date:  1988-04-05

9.  Synthesis, processing, and secretion of recombinant human factor VIII expressed in mammalian cells.

Authors:  R J Kaufman; L C Wasley; A J Dorner
Journal:  J Biol Chem       Date:  1988-05-05       Impact factor: 5.157

10.  Tyrosine sulfation is a trans-Golgi-specific protein modification.

Authors:  P A Baeuerle; W B Huttner
Journal:  J Cell Biol       Date:  1987-12       Impact factor: 10.539

View more
  20 in total

1.  Reevaluation of the determinants of tyrosine sulfation.

Authors:  H B Nicholas; S S Chan; G L Rosenquist
Journal:  Endocrine       Date:  1999-12       Impact factor: 3.633

2.  Mutants of complement component C3 cleaved by the C4-specific C1-s protease.

Authors:  P Mathias; C J Carrillo; N E Zepf; N R Cooper; R T Ogata
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-01       Impact factor: 11.205

3.  The human estrogen sulfotransferase: a half-site reactive enzyme.

Authors:  Meihao Sun; Thomas S Leyh
Journal:  Biochemistry       Date:  2010-06-15       Impact factor: 3.162

4.  Sulfation, the up-and-coming post-translational modification: its role and mechanism in protein-protein interaction.

Authors:  Amina S Woods; Hay-Yan J Wang; Shelley N Jackson
Journal:  J Proteome Res       Date:  2007-01-26       Impact factor: 4.466

5.  Structural basis for activation of the complement system by component C4 cleavage.

Authors:  Rune T Kidmose; Nick S Laursen; József Dobó; Troels R Kjaer; Sofia Sirotkina; Laure Yatime; Lars Sottrup-Jensen; Steffen Thiel; Péter Gál; Gregers R Andersen
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-04       Impact factor: 11.205

6.  Tyrosine sulfation is required for agonist recognition by glycoprotein hormone receptors.

Authors:  S Costagliola; V Panneels; M Bonomi; J Koch; M C Many; G Smits; G Vassart
Journal:  EMBO J       Date:  2002-02-15       Impact factor: 11.598

Review 7.  The structural role of receptor tyrosine sulfation in chemokine recognition.

Authors:  Justin P Ludeman; Martin J Stone
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

8.  Detection and purification of tyrosine-sulfated proteins using a novel anti-sulfotyrosine monoclonal antibody.

Authors:  Adam J Hoffhines; Eugen Damoc; Kristie G Bridges; Julie A Leary; Kevin L Moore
Journal:  J Biol Chem       Date:  2006-10-17       Impact factor: 5.157

9.  Antagonism of the complement component C4 by flavivirus nonstructural protein NS1.

Authors:  Panisadee Avirutnan; Anja Fuchs; Richard E Hauhart; Pawit Somnuke; Soonjeon Youn; Michael S Diamond; John P Atkinson
Journal:  J Exp Med       Date:  2010-03-22       Impact factor: 14.307

10.  Analysis of sequence requirements for protein tyrosine sulfation.

Authors:  G L Rosenquist; H B Nicholas
Journal:  Protein Sci       Date:  1993-02       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.